Abbott Reports First-in-Human Leadless Pacing Procedures Using AVEIR Conduction System Pacing (CSP) Leadless Pacemaker
Shots:
- Abbott has successfully completed its first in-human leadless left bundle branch area pacing (LBBAP) procedures utilizing its AVEIR Conduction System Pacing (CSP) leadless pacemaker to treat patients with slower heart rhythms
- The procedure was a part of feasibility study assessing the safety and efficacy of the AVEIR CSP leadless pacemaker system
- CSP is a technique that stimulates the left bundle branch area for physiological pacing using traditional pacemaker to improving heart response. The US FDA designated AVEIR CSP system with BDD for LBBAP
Ref: Abbott | Image: Abbott
Related News: Abbott Reports 2 Years Data from the LIFE-BTK Study of Esprit BTK System to Treat Peripheral Artery Disease Below the Knee
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
